Promising Results: Weekly Weight Loss Drug Shows Significant Benefits for Obese Diabetics
New trial data reveals that obese individuals with diabetes may be able to shed up to 2.5st (stones) by using a weekly weight loss medication. The drug in question is called Tirzepatide and is manufactured by Eli Lilly. By mimicking hormones in the body, Tirzepatide helps people feel fuller for longer after eating, leading to weight loss. Having gained approval from the medicines watchdog last year, this injection-based drug is expected to become available to patients in the UK soon. The results of the phase three trial demonstrate that overweight or obese patients with Type 2 diabetes achieved significantly greater weight loss when using Tirzepatide in comparison to relying solely on diet and exercise. Participants who took a 15mg dosage of the drug once a week lost up to 16% of their body weight, equivalent to around 2.5st, while those on a 10mg dosage lost up to 13%, or 2.1st. It's worth noting that all trial participants, including the placebo group, followed a low-calorie diet